Abstract:Histidine is an important amino acid involved in enzyme catalysis and metal binding in many proteins. Bacteria, fungi and plants synthesise histidine via the 10 step histidine pathway, whereas histidine is an essential amino acid required in the diet of animals. The synthesis of histidine is energetically expensive with about 41 ATP needed to produce one histidine. As a result the histidine biosynthetic pathway is tightly regulated and some microorganisms can consume excess histidine as a nitrogen and carbon source via a histidine utilisation (hut) pathway. The absence of a histidine biosynthetic pathway in mammals makes it a good target for the development of antimicrobial and antifungal drugs as well as herbicides. In addition to an overall regulation of the histidine synthesis by charged histidyl-tRNA and histidyl-tKNA synthetase, the histidine pathway is regulated in various ways by the first enzyme of the pathway ATP-phosphoribosyltransferase (HisG). The enzyme catalyses the condensation of ATP and phosphoribosylpyrophosphate (PRPP) to form phosphoribosyl-ATP (PR-ATP) and is feedback regulated by histidine, the end product of the pathway. Furthermore, HisG is inhibited by its product PR-ATP and also by AMP and ppGpp, reflecting the overall energy status of the cell. Inhibition of HisG coincides with a change in aggregation state, in which the active dimers form inactive hexamers. Some bacterial genomes contain a hisG gene, which lacks about 80 residues at the C-terminus, but have an additional gene, hisZ. This short form of HisG itself is inactive and forms an active complex with HisZ. This thesis describes the solution of the 3-dimensional structures of the hexameric forms of bacterial HisGs by X-ray crystallography. The structure of the Escherichia coli HisG was determined in the presence of the inhibitors AMP and PR- ATP. Additionally, a histidine-bound structure of HisG from the thermophilic bacterium Methanobacteriim thermoautotrophicum has been obtained. The monomer of HisG comprises of three a/p domains. The first two domains show a periplasmic protein-like fold with the active site located in a cleft between the two domains. The C-terminal domain, similar to Pn signal transduction proteins, binds histidine and is mainly involved in the formation of the hexamers. Additionally the structure of HisG represents a new type of phosphoribosyltransferase. The structure of the binary complex with AMP has allowed the identification of the PRPP binding site and explains the competitive inhibition by AMP with respect to both substrates. Furthermore the AMP binary structure and the PR-ATP-complexed structure identified the binding site of the ATP purine ring. The histidine-bound structure explains the histidine inhibition by disruption of the PRPP binding site on the dimer interface by elongation of the dimer and hence the hexanier. A mode of inhibition common to all the inhibitors investigated is the formation of hexamers upon inhibitor binding which buries the active sites in the inside of the hexamer and makes the sites less accessible to the substrates. Mutational and kinetic analysis showed that the extra C-terminal domain in the long form of HisG is not essential for activity. Subsequently, it was demonstrated that the naturally short form of HisG can be activated by thermal energy. This suggests a tense conformation for the short form of the enzyme which can be relaxed and activated by forming an oligomeric complex with HisZ. The structure of an unidentified protein in the histidine utilisation (hut) pathway from Pseudomonas aeruginosa, PAS104, was determined to better than 1 A resolution. Solution of the structure was accomplished by a unique approach combining SIRAS phasing with direct methods (Sayre equation). PAS104 is an all-beta protein with a bicupin fold. One of the P-barrels is open and accommodates a small molecule binding site. A different conformation of PAS 104 was obtained from a second structure solved using a different crystal form. Comparison of the structures and interactions in the active site identifies glutamate or derivatives (intermediates in the hut pathway) as possible substrates, which can induce a conformational change and may give PAS104 a regulatory function.

Solution structure and catalytic mechanism of human protein histidine phosphatase 1.

1 H, 13 C, and 15 N resonance assignments of human phosphohistidine phosphatase 1 (PHPT1)

Theoretical Studies on the Catalytic Cycle of Histidine Acid Phosphatases Revealing an Acid Proof Mechanism

The Crystal Structure of a Low-Molecular-weight Phosphotyrosine Protein Phosphatase.

HOMOLOGY MODELING AND MOLECULAR DYNAMICS STUDY OF HUMAN INOSINE TRIPHOSPHATE PYROPHOSPHATASE

Histidine Phosphorylation: Protein Kinases and Phosphatases

Snapshots during the catalytic cycle of a histidine acid phytase reveal an induced-fit structural mechanism

Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation.

Structural studies on histidine metabolism in microorganisms

Mapping the Structural Path for Allosteric Inhibition of a Short-Form ATP Phosphoribosyltransferase by Histidine

Seeing the Process of Histidine Phosphorylation in Human Bisphosphoglycerate Mutase

Crystal Structure of Human Protein-Tyrosine Phosphatase SHP-1.

Effect of histidine protonation state on ligand binding at the ATP-binding site of human protein kinase CK2

Investigation of the Role of Arg301 Identified in the X-ray Structure of Phosphite Dehydrogenase

Structural and Biochemical Characterization of a Cyanobacterial PP2C Phosphatase Reveals Insights into Catalytic Mechanism and Substrate Recognition

Structure and Molecular Dynamics Simulations of Protein Tyrosine Phosphatase Non-Receptor 12 Provide Insights into the Catalytic Mechanism of the Enzyme

Solution Structure of A Low-Molecular-Weight Protein Tyrosine Phosphatase from Bacillus Subtilis

Crystal structure and mechanistic studies of the PPM1D serine/threonine phosphatase catalytic domain

Structure-Based Discovery of Small Molecule Inhibitors Targeted to Protein Tyrosine Phosphatase 1B

Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition.

Structure-Based Design and Synthesis of Small Molecule Protein-Tyrosine Phosphatase 1b Inhibitors